DOCSLIB.ORG

The Sexually Transmitted Infection 'Check

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Sexually Transmitted Infection 'Check THEME: STIs The sexually transmitted Linda Dayan, infection ‘check up’ Catriona Ooi Screening for STIs in general practice BACKGROUND Many sexually transmitted infections (STIs) and blood borne viruses (BBV) such as HIV are asymptomatic. Early detection is important for minimising associated risks. With appropriate treatment and management (including contact tracing) it is possible to substantially reduce morbidity as well as transmission to sexual partners and the neonate. OBJECTIVE This paper outlines which tests should be administered to otherwise ‘well’ individuals. It also examines the questions of when, why and how to respond to requests for an STI ‘screen’ or ‘check up’. DISCUSSION Testing and screening for asymptomatic STIs and BBV are important, Linda Dayan, especially in situations where proven interventions can decrease morbidity and BMedSc, MBBS, transmission. Screening for STIs also provides the opportunity in a one-on-one DipRACOG, MM consultation for health promotion. Sexually transmitted infection testing can also initiate (VenSci), FACSHP, MRCMA, is Director, a conversation about ‘safer sex’ and may help address other concerns patients may have. Sexual Health Services, Northern Sydney Health, creening’ is defined as testing carried out individual concerns, public health and cost issues New South Wales. ‘Samong apparently well people to identify need to be balanced when considering any screen- Catriona Ooi, MBBS, those at an increased risk of a disease or disorder.1 ing tests. BSc (Med), is a Screening for bacterial sexually transmitted infec- registrar, Department of Sexual Health, tions (STIs) offers opportunities for early Responding to the request for a sexual health ‘check up’ Royal North Shore intervention and treatment and has been shown to and Manly Hospitals, reduce rates of transmission2 thereby decreasing Asymptomatic patients may request an ‘STI check New South Wales. morbidity. up’ after entering a new sexual relationship, before Screening can be based on selective criteria for embarking on unprotected sex. Couples are those at higher risk or routinely offered to every- encouraged to get ‘tested’ before ceasing condom one. The cost effectiveness of each approach use, and efforts should be made to ensure that both depends on the prevalence of infection within the partners are tested. community or group being ‘screened’, the type of Patients may also present requesting testing test used, its specificity and sensitivity, the cost of because they are unwilling to divulge other risks, the test and the availability of an appropriate inter- may be symptomatic or worried. Direct question- vention to minimise morbidity and/or mortality.3 ing about specific symptoms should form part of Screening to detect asymptomatic infection should the history. only occur if it is possible to decrease transmission, Patient concern and request for a ‘check up’ morbidity or mortality through intervention. may be a surrogate marker for other health issues Detection should not cause physical or psychologi- such as erectile dysfunction.4 A request for an HIV cal harm to the patient. test may reveal concerns about partner fidelity, Medicolegal issues may also need to be consid- sexuality issues or a sexual assault.5 Anyone who ered when screening for STIs. This, combined with has experienced sexual contact may present for a Reprinted from Australian Family Physician Vol. 32, No. 5, May 2003 • 297 n The sexually transmitted infection ‘check up’ – screening for STIs in general practice Table 1. Our recommendation for STI and BBV screening Table 2. Suggested open ended questions for taking a sexual history Screening asymptomatic individuals at risk through noncommercial sexual activity • Why do you think you have been at risk of STIs • Anyone who asks for a test or HIV? • Contact of anyone with an STI • Which STIs are you particularly concerned about? • Young sexually active people under 25 years of age (chlamydia especially) • What do you think I need to know about your • Unprotected sex (especially overseas country of higher HIV risk) sexual practises to ensure that I order the best tests? • Multipartnered individuals • What do you do to protect yourself against HIV • Recent change in sexual partner infection and other STIs? Regular or periodic STI testing for those at higher risk due to occupational • In what situations would you be less likely to risk/sexual risk and/or public health reasons use condoms? • Commercial sex workers (regular screening for STIs to ensure safety to and • Tell me about your use of condoms, for anal from clients) sex, vaginal sex, oral sex? • Men having sex with other men (multisite testing) (especially multisite gonorrhoea and chlamydia) (Table 5*) • Health professionals at risk of needlestick injury (HIV, HCV, HBV [if not vaccinated]) more about the type of check up you want?’ or Other groups to be considered ‘What do you expect the check up to reveal?’ may • Pregnant women (especially HIV, syphillis, hepatitis B and C, and elicit useful information about the reasons for pre- chlamydia/gonorrhoea, +/– BV) sentation (Table 2). Some patients may be • Pregnant women referred for termination of pregnancy (TOP) (BV, chlamydia and gonorrhoea, important to decrease risks of pelvic reluctant to disclose information unless asked inflammatory disease post-TOP) direct closed questions about their sexual activity • HIV positive individuals (concomitant infections have been shown to (Table 3). increase risk of HIV transmission) Initially, the patient interview should establish the reason for presentation, identify risks of infec- tion and clarify any misconceptions the patient may have. The sexual history and risk assessment may reveal sexual practices or issues that will focus the sexual health screen and requests for testing consultation accordingly; for example, if the patient should not be dismissed, regardless of risk. Sexual divulges that they are a commercial sex worker or a history and risk assessment are important to tailor homosexual man more regular and multisite STI testing, counselling and education (Table 1). screening would be required (Table 5). STI risk assessment Screening for STIs in general An accurate history should aid the practitioner in practice – what investigations and why? assessing the likelihood of a positive result, as well as targeting patient education and providing essen- Clinical time pressures, concerns about confiden- tial health promotion information (Table 2, 3). The tiality and structural barriers imposed by the limitations of the tests themselves, incubation and federal government to limit pathology testing by window periods of the tests should also be dis- general practitioners may make comprehensive cussed (Table 4). screening for STIs difficult.7 Testing over two con- Consultation in a private, nonthreatening, non- sultations may make the process more feasible. judgmental forum may help clarify reasons for presentation. Use language that you feel comfort- HIV able with and that the patient understands. It is Despite human immunodeficiency virus (HIV) also important to explain to the patient why you sero prevalence in Australia estimated at are asking certain questions: ‘In order to establish 66:100.000,8 the consequences of undiagnosed and your level of risk of HIV, I will need to ask you untreated HIV infection are fatal. Until a decade some personal and private questions’. ago little could be offered to HIV positive patients. Open ended question such as: ‘Can you tell me However, recent years have seen a paradigm shift 298 • Reprinted from Australian Family Physician Vol. 32, No. 5, May 2003 The sexually transmitted infection ‘check up’ – screening for STIs in general practice n Table 3. Suggested closed questions Table 4. Which test to use for STI screening and window for taking a sexual history periods of common STIs Present sexual history Screening test Window Comment • Are you in a sexual relationship at the period moment? With a male or female partner? HIV HIV Ab/Ag 6–12 weeks Newer tests combine HIV • When did you last have sex? Was that with a antigen with HIV antibody male or female partner? Casual or regular Syphilis EIA 2–12 weeks Repeat serology for those partner? or with suspected exposure • Have you had any other partners? While in this RPR/VDRL + 3–12 weeks relationship? TPPA/TPHA • Have you had a change in partner? Hepatitis B HepB coreAb 4–24 weeks Past exposure • Do you have vaginal sex? oral sex? anal sex? HepB sAg 4–8 weeks Carrier status/recent infection HepB sAb Past vaccination • What percentage of the time do you use condoms for vaginal sex? anal sex? oral sex? Hepatitis C HepC Ab 2–26 weeks Past sexual history Chlamydia First catch urine 2–7 days Men and women PCR/LCR • How many sexual partners you have had in the Cervical swab In women: sensitivity of cervical past? PCR/LCR swab slightly greater than • Without condoms? (do not say ‘protection’, ie. urine test it could mean ‘the oral contraceptive pill’) Gonorrhoea First catch urine 24 hours Men (beware gonorrhoea • Do you have sex with men, women or both? Gonorrhoea PCR false positives – confirm • Have you ever had sex with someone of the culture/PCR with culture) same sex? Cervical culture/ Women (beware NG PCR/LCR Overseas risk (as other countries have different PCR false positives – confirm with rates of HIV infection) culture) • Have you ever had sex with someone from overseas? • Where were they from? Nonconsensual sex • Has anyone forced you to have sex that you Table 5. Testing
Load more

Recommended publications
  • Giardia Intestinalis, Also Known As G
    For Vets General Information Giardiosis is a disease caused by the protozoan parasite Giardia intestinalis, also known as G. duodenalis or G. lamblia. It is the most commonly identified pathogen in outbreaks of waterborne human disease in the USA. Clinical disease typically manifests as diarrhea. By far the most common source of infection for people is surface water contaminated by human fecal material. Within G. intestinalis there are a number of genotypes which are grouped into “assemblages” A to F. Assemblages A and B are capable of infecting several animal species, as well as humans. Other assemblages occur only in animals. Giardia, including zoonotic and species-specific assemblages, occurs frequently in dogs, and less commonly in cats, but the parasite can infect many species including beavers, livestock, ferrets, guinea pigs, gerbils, rats and chinchillas. The risk of zoonotic transmission of Giardia from pets remains controversial and unquantified, but the potential certainly exists. It is therefore important to be aware of the potential risk and encourage pet owners and people who handle animals to take steps to help prevent the spread of Giardia. Prevalence and Risk Factors Humans Giardiosis is endemic worldwide. In industrialized countries the prevalence of Giardia in people is estimated to be between 1-7%, but it may be as high as 50% in developing countries. All age groups are equally affected during epidemics, but both subclinical infection and clinical disease are more common in children in endemic areas. Outbreaks occur regularly in childcare facilities. Immunocompromised individuals are also more commonly affected than members of the general population.
    [Show full text]
  • STI Screening Timetable
    Patient Education Information from University Health Center’s STI Screening Clinic Page 1 of 1 STI Screening Timetable How long until STI (sexually transmitted infection) screening tests turn positive? How long until STI symptoms might show up? The time between infection and a positive test, or between infection and symptoms, is variable and depends on many factors, including the behavior of the infectious agent, how and where the body is infected, and the state of a person’s immune system and personal health. Many STIs don’t have any symptoms. The incubation period times listed in the chart below are averages only. If you have further questions or concerns, you can schedule an appointment with a clinician at 541-346-2770. STI screening test Window period (time from exposure until Incubation period (time between exposure and screening test turns positive) when symptoms appear) Chlamydia (urine specimen or swab of 1 week most of the time Often no symptoms vagina, rectum, throat) 2 weeks catches almost all 1-3 weeks on average Gonorrhea (urine specimen on swab of 1 week most of the time Often no symptoms, especially vaginal vagina, rectum, throat) 2 weeks catches almost all infections usually within 2-8 days but can be up to 2 weeks Syphilis (blood test, RPR) 1 month catches most Often symptoms too mild to notice 3 months catches almost all 10-90 days average 21 days HIV (oral cheek swab) 1 month catches most Sometimes mild body aches and fever within 1-2 3 months catches almost all weeks then can be months to years HIV (blood test, antigen/antibody
    [Show full text]
  • Hepatitis B and C Testing: Why? Who? How? a Guidance Paper on Testing in Community and Harm Reduction Settings 1 Colophon
    Hepatitis B and C testing: why? who? how? A guidance paper on testing in community and harm reduction settings 1 Colophon This paper is a product of the Correlation Hepatitis C Initiative. You can access the paper at www.hepatitis-c-initiative.eu Author: Danny Morris Review: M. Harris, A. Kautz, A. Leicht, H. Lochtenberg, E. Schatz Copyright © 2016 Copyrights remains with the publisher Correlation Network PO Box 10887 1001 EW Amsterdam The Netherlands Phone.: +31 20 5317600 Fax.: +31 20 4203528 [email protected] Correlation Network is a part of the international activities of the Regenboog Groep. For more information: www.deregenboog.org The production of this paper has been supported by an unrestricted grant from Gilead Sciences Europe Ltd 2 Acknowledgements We want to thank the author Danny Morris and all who helped to draft this paper and the Regenboog Group, Abbvie and GILEAD for their financial support of the Hepatitis C Initiative. Eberhard Schatz Correlation Hepatitis C Initiative Amsterdam, December 2016 “The Hepatitis C Initiative aims to enhance the momentum of current HCV treatment opportunities and strives for universal access to essential HCV prevention and treatment for the most affected and under-served communities: people who use drugs.” 3 Content Chapter 1: Introduction 6 1.1 Hepatitis B and C infect one in fifty adults in the European Region 9 1.2 Higher rates of hepatitis among vulnerable groups 9 1.3 A public health approach to hepatitis 9 1.4 Harm reduction as prevention 10 1.5 Diagnosing hepatitis B and C 10 1.6 Awareness raising - key recommendations 11 1.7 Testing and diagnosis - key recommendations 13 Chapter 2: Who should be tested 14 2.1 Barriers to testing 16 2.2 Barriers to testing and treatment may include 16 2.3 Overcoming barriers to testing 17 2.4 Testing as standard practice 18 2.5 Pre and post-test discussion 18 2.6 Serological testing for viral hepatitis 20 4 Chapter 3: Screening technologies and development of non-invasive techniques 22 3.1 Venapuncture 23 3.2 Dried blood spot testing 24 3.3.
    [Show full text]
  • Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations
    Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations Shimian Zou, Susan L. Stramer, and Roger Y. Dodd Over the past 20 years, there has been a major increase virus (HIV) and human T-cell lymphotropic virus did in the safety of the blood supply, as demonstrated by not. The incidence (/100 000 person-years) of HIV and declining rates of posttransfusion infection and reduc- HCV among repeat donors showed apparent increases tions in estimated residual risk for such infections. from 1.55 and 1.89 in 2000 through 2001 to 2.16 Reliable estimates of residual risk have been possible and 2.98 in 2007 through 2008. These observed within the American Red Cross system because of the fluctuations confirm the need for continuous monitor- availability of a large amount of reliable and consistent ing and evaluation. The residual risk of HIV, HCV, and data on donations and infectious disease testing human T-cell lymphotropic virus among all allogeneic results. Among allogeneic blood donations, the pre- donations is currently below 1 per 1 million donations, valence rates of infection markers for hepatitis C virus and that of hepatitis B surface antigen is close to 1 per (HCV) and hepatitis B virus have decreased over time, 300 000 donations. although rates for markers of human immunodeficiency © 2012 Elsevier Inc. All rights reserved. HE BLOOD SUPPLY in the United States DEMOGRAPHY OF DONOR POPULATIONS T and many other countries has become safer In 2008, a total of 3 830 094 volunteer blood than ever, thanks to continuing improvements in donors successfully made 6 638 877 blood dona- donor selection and testing, along with broad tions to ARC Blood Services, with whole blood and improvements in public health.
    [Show full text]
  • Sexually Transmitted Infection Prevention and Treatment
    Sexually Transmitted Infection Prevention and Treatment Kevin L. Ard, MD, MPH Massachusetts General Hospital, The Fenway Institute Disclosures I have no financial disclosures. Doxycycline PEP is not FDA-approved. Learning objectives 1. Describe the epidemiology of syphilis, chlamydia, gonorrhea, and other STIs among LGBTQ populations 2. Summarize optimal screening strategies for STIs. 3. Outline approaches to STI control that can be integrated into primary care. 3 Caveats ▪ Many (most?) LGBTQ people do not face a high risk of STIs. ▪ Clinical care must be individualized, not based on group risk. ▪ Data about STIs among cisgender WSW are limited. ▪ Terms that describe identity and behavior are imperfect and change over time. The rate of chlamydia diagnosis is increasing. Sexually Transmitted Disease Surveillance 2017, CDC Proportion of STI clinic patients testing positive for chlamydia Sexually Transmitted Disease Surveillance 2017, CDC The rate of gonorrhea diagnosis is increasing. Sexually Transmitted Disease Surveillance 2017, CDC MSM face an increasing disparity in the rate of gonorrhea. Sexually Transmitted Disease Surveillance 2017, CDC Antimicrobial resistance in gonorrhea is increasing. Resistanc e Elevated MICs Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2017. Atlanta: U.S. Department of Health and Human Services; 2018. Neisseria gonorrhoeae — Percentage of Urethral Isolates with Elevated Azithromycin Minimum Inhibitory Concentrations (MICs) (≥2.0 µg/ml) and Elevated Ceftriaxone MICs (≥0.125 μg/ml) by Reported Sex of Sex Partners, Gonococcal Isolate Surveillance Project (GISP), 2011–2017 A. Azithromycin B. Ceftriaxone * No cases of elevated ceftriaxone MICs were reported among MSM in 2017. ACRONYMS: MSM = Gay, bisexual, and other men who have sex with men (collectively referred to as MSM); MSW = Men who have sex with women only.
    [Show full text]
  • Potential Biomarkers As an Indicator of Vertical Transmission of Johne's
    Original Article J Vet Sci 2017, 18(S1), 343-349ㆍhttps://doi.org/10.4142/jvs.2017.18.S1.343 JVS Potential biomarkers as an indicator of vertical transmission of Johne’s disease in a Korean native cattle farm Hong-Tae Park1,†, Hyun-Eui Park1,†, Yong-Il Cho2, Eui-Hyung Kim3, Myunghwan Jung1, Seung Won Shin1, Su-Hyung Lee4, Dae-Yong Kim4, Han Sang Yoo1,* Departments of 1Infectious Diseases and 4Veterinary Pathology, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea 2Department of Animal Science & Technology, Suncheon National University, Suncheon 57922, Korea 3National Institute of Animal Science, Rural Development Administration, Pyeongchang 25340, Korea Paratuberculosis (PTB) is caused by Mycobacterium avium subsp. paratuberculosis (MAP) and is one of the most widespread and economically important diseases in cattle. After birth, calves are raised with natural breast feeding without separation from their mothers in most Korean native cattle (Hanwoo breed) farms. Vertical transmission of PTB has been reported, but the exact PTB infection route has not been revealed in Hanwoo farms. Calves of MAP seropositive dams were tested for MAP presence and MAP antibodies in feces and tissues. MAP was detected in calf tissues by using polymerase chain reaction. Expressions of genes reported to be prognostic biomarkers of MAP infection changed in both calves and cows (p ＜ 0.05). Expression of two genes (HGF and SERPINE1) were significantly decreased in MAP-infected cattle and their offspring (p ＜ 0.01). The results suggest that biomarker gene expression profiles can be useful in detecting early stage MAP infection. Based on the results, complete eradication of MAP may be possible if accurate diagnostic methods to detect infected calves are added to the current PTB eradication strategy, which, because infected individuals are likely to develop into fecal MAP shedders at any time, includes isolation of new born calves and feeding sterilized colostrum.
    [Show full text]
  • Asymptomatic Subclinical Cases of Coronavirus Disease 2019 Without Viral Transmission in Three Independent Families
    Infection and Drug Resistance Dovepress open access to scientific and medical research Open Access Full Text Article SHORT REPORT Asymptomatic Subclinical Cases of Coronavirus Disease 2019 without Viral Transmission in Three Independent Families This article was published in the following Dove Press journal: Infection and Drug Resistance Xian Zhang1,* Purpose: There is increasing evidence indicating that considerable fractions of cases of Liting Chen2,* SARS-CoV-2 infection are asymptomatic. We traced three asymptomatic clusters to inves­ Jia Wei2 tigate the infectivity of subclinical cases of coronavirus disease 2019 (COVID-19). Jianfeng Zhou2 Patients and Methods: Three medical staff who were asymptomatic were diagnosed with Yang Cao2 coronavirus disease 2019 by serological tests. Their close contacts were systematically evaluated based on COVID-19-related symptoms, nucleic acid tests, serological tests, and Gaoxiang Wang2 chest computed tomography (CT) as needed to determine if they were infected by SARS- 1Department of Ophthalmology, Tongji CoV-2. Hospital, Tongji Medical College, Huazhong University of Science and Results: None of the staff’s close contacts, including 10 family members, were infected by Technology, Wuhan, Hubei 430030, the indexes, even though no protective measures were taken. 2 People’s Republic of China; Department Conclusion: The infectivity of asymptomatic subclinical infection patients of coronavirus of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of disease 2019 seems to be low. Science and Technology, Wuhan, Hubei Keywords: SARS-CoV-2, COVID-19, asymptomatic, close contact, infectivity 430030, People’s Republic of China *These authors contributed equally to this work Introduction Toward the end of 2019, there was an outbreak of severe acute respiratory syn­ drome coronavirus 2 (SARS-CoV-2).
    [Show full text]
  • Subclinical Avian Influenza A(H5N1) Virus Infection in Human, Vietnam
    DISPATCHES leading to hospital admission. Despite intensive care and Subclinical Avian treatment with oseltamivir and antibiotics, the disease pro- gressed, and he died 2 days later. Influenza A(H5N1) A throat swab taken from the index case-patient on day 3 of illness was tested by reverse transcription PCR, and Virus Infection in results were positive for influenza A(H5N1) virus. Hemag- Human, Vietnam glutination inhibition (HI) and microneutralization (MN) tests for H5N1-specific antibodies were negative in sam- Mai Quynh Le, Peter Horby, Annette Fox, ples taken during the acute phase of illness (online Techni- Hien Tran Nguyen, Hang Khanh Le Nguyen, cal Appendix, wwwnc.cdc.gov/EID/article/19/10/13-0730- Phuong Mai Vu Hoang, Khanh Cong Nguyen, Techapp1.pdf). Menno D. de Jong, Rienk E. Jeeninga, On day 5 of illness of the index case-patient, a contact H. Rogier van Doorn, Jeremy Farrar, investigation was initiated. Throat swab specimens were and Heiman F.L. Wertheim collected from 4 household members and 1 close contact of the index case-patient: his spouse (age 47 years), daughter Laboratory-confirmed cases of subclinical infection (age 18 years), daughter-in-law (age 25 years), and grand- with avian influenza A(H5N1) virus in humans are rare, and son (age 1 year) and an unrelated man (age 43 years). None the true number of these cases is unknown. We describe of the contacts had signs or symptoms. Infection control the identification of a laboratory-confirmed subclinical case measures were initiated, and all household members were in a woman during an influenza A(H5N1) contact investiga- tion in northern Vietnam.
    [Show full text]
  • Management of Water-Related Microbial Diseases
    Management of Water-related Microbial Diseases First Edition 2003 The Department of Water U Affairs and Forestry Tl I75/DJ Water Research Commission REPORTS IN THIS SERIES This guide forms part of a series which is aimed at water supply agencies, water resource managers, workers in health-related fields, as well as communities throughout South Africa. The guide is intended to provide awareness-building information to keep water supplies clean of microbial contamination and thus reduce the incidence of water-related diseases. The publication of this report emanates from a WRC consultancy no 431: Guide on water-related microbiological diseases. The following documents form part of this series of Guides on the Management of Water-related Microbial Diseases: Vol: 1 What is the problem? - Disease Characteristics. Vol: 2 What causes the problem;1 - A What to Do for Water Suppliers following Diarrhoea Incidents. ' Vol: 3 How great is the problem? - Health Impact Assessment.1 Vol: 4 How dangerous is the problem? - Communicating the Risk.' Vol: 5 What we and our children need to know - Health & Hygiene Awareness.1 Still in preparation. This guide is available from: Director: Institute for Water Quality Studies Water Research Commission Department of Water Affairs & Forestry Private Bag X03 Private Bag X313 Geztna Pretoria 0031 0001 South Africa Tel: 012 808 0374 Tel: 012 330 0340 Fax: 012 808 0338 Fax: 012 331 2565 Disclaimer This report has been reviewed by the Water Research Commission (WRC) and approved for 1 publication. Approval does not signify that the contents necessarily reflect the views and policies of the WRC, nor does mention of trade names or commercial products constitute endorsement or f recommendation for use.
    [Show full text]
  • STD (Sexually Transmitted Disease) Or STI (Sexually Transmitted Infection): Should We Choose? Janet Byron Anderson, Phd
    STD (sexually transmitted disease) or STI (sexually transmitted infection): Should we choose? Janet Byron Anderson, PhD 1. Clinical foundation of the problem Another surprise: Documented incidence had shown Each of the terms—“sexual(ly)”, “transmitted”, “disease”, that the two routes of sexual transmission were male-to- and “infection”—is problematic independently, as this female and male-to-male. However, on 15 July 2016 the study will show. Moreover, co-occurring variants, used CDC reported the first case of suspected female-to-male as synonyms in English medical articles worldwide, ag- sexual transmission in New York City [4]. Since 2008, gravate the problem. The purpose of this study is to pro- then, the Zika virus has shown that it is now sexually pose a single term that can stimulate discussion about transmissible. “Transmissible” denotes a potential, and is whether the co-occurring variants are clinically and lin- distinct from “transmitted”, which denotes a reality. guistically justifiable—especially now, when STDs/STIs To say that Zika has proved to be transmissible through have become a global health problem, and public health sexual contact means that it can be transmitted through agencies in every country are scrambling to educate their sex but that it need not be (Zika remains a chiefly vec- citizens. [Until the presentation advances to the point tor-borne disease). However, cases reported since 2008 where the question posed in the title can be definitively document the reality of transmittedness through sexual answered, I’ll use the expression “STD/STI” or the terms contact. “illness(es)” and “condition(s)”.] The predisposing epidemiologic context will first be clar- This carefully differentiated language is used by the ified, for it sheds light on two of the problematic terms: European Centre for Disease Prevention and Control chiefly “transmitted” but also “sexual(ly)”.
    [Show full text]
  • The Cursed Duet Today: TB and HIV-Coinfection
    The cursed duet today: TB and HIV-coinfection Simon Tiberi#1, Anna Cristina C. Carvalho#2, Giorgia Sulis#3, Devan Vaghela#4, Adrian Rendon5, Fernanda C de Q Mello6, Ananna Rahman7, Nashaba Matin8, Alimuddin Zumla9, Emanuele Pontali10 # contributed equally Address of Correspondence: Division of Infection, Royal London Hospital, Barts Health NHS Trust. 80 Newark St. London E1 2ES, United Kingdom. Email: [email protected], Tel: +44 745001158 Affiliations 1. Division of Infection, Royal London Hospital, Barts Health NHS Trust, 80 Newark Street London E1 2ES, United Kingdom. Email: [email protected] 2. Laboratory of Innovations in Therapies, Education and Bioproducts, (LITEB), Oswaldo Cruz Institute (IOC), Fiocruz, Rio de Janeiro, Brazil. Email: [email protected] 3. University Department of Infectious and Tropical Diseases, World Health Organization Collaborating Centre for TB/HIV co-infection and TB elimination, University of Brescia, Brescia, Italy. Email: [email protected] 4. Department of Respiratory Medicine, Royal London Hospital, Barts Health NHS Trust, 80 Newark Street London E1 2ES, United Kingdom. Email: [email protected] 5. Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias, Hospital Universitario de Monterrey, Monterrey, Nuevo León UANL, México. Email: [email protected] 6. Instituto de Doenças do Tórax (IDT)/Clementino Fraga Filho Hospital (CFFH), Federal University of Rio de Janeiro, Rua Professor Rodolpho Paulo Rocco, n° 255 - 1° Andar - Cidade Universitária - Ilha do Fundão, 21941-913, Rio De Janeiro, Brazil. Email: [email protected] 7. Department of Respiratory Medicine. Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, United Kingdom. Email: [email protected] 8.
    [Show full text]
  • Using Knowledge of HIV Status As an HIV Prevention Strategy
    From Prevention in Focus, Spring 2014 Unknown, negative or positive? Using knowledge of HIV status as an HIV prevention strategy By James Wilton and Tim Rogers As front-line workers in HIV prevention, it is important to understand what prevention strategies clients are using and how they understand the risks associated with them. A common HIV prevention strategy used by gay men and other men who have sex with men (MSM) is known as “serosorting” and involves limiting all – or just “high-risk” – sexual activities to partners who have the same HIV status. For example, an HIV-negative person may choose to only have condomless sex with other people who are HIV negative or an HIV-positive person may choose to only have condomless sex with other people who are HIV positive. This strategy is used in the context of different types of relationships, such as stable, casual, monogamous and non-monogamous relationships. This article focuses on how often serosorting is used, how well it works, and how knowledge of HIV status can be effectively used as a prevention strategy. The article only covers serosorting strategies that are based on individuals identifying themselves or others as HIV-positive or HIV-negative. It does not address other factors, such as viral load or use of other HIV prevention strategies, which play a very important role in assessing HIV risk. For information on these other strategies, please see the resource list at the end of the article. How common is serosorting? Serosorting is quite common among MSM in Canada and other parts of the world.
    [Show full text]